2,4,5-Trisubstituted imidazolines and pharmaceutical composition

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424263, 546278, 548348, 548351, C07D23330, C07D40104, A61K 31415

Patent

active

043082777

ABSTRACT:
Compounds of the formula ##STR1## in which R.sub.1 and R.sub.2 independently of one another are substituted or unsubstituted aryl or hetero-aryl groups, R.sub.3 is hydrogen or lower alkyl and R.sub.4 is a substituted or unsubstituted aliphatic hydrocarbon radical, and their pharmaceutically usable salts. These compounds possess immunoregulatory, antithrombotic and antiinflammatory properties and can be used as active ingredients in medicaments. They are prepared, for example, by reacting compounds of the formulae ##STR2## in which one of the radicals X and Y is mercapto, which can be in the form of a salt, and the other is a radical replaceable by etherified mercapto, with one another.

REFERENCES:
patent: 2981739 (1961-04-01), Bimber
patent: 4182769 (1980-01-01), Cherkofsky et al.
patent: 4190666 (1980-02-01), Cherkofsky et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,4,5-Trisubstituted imidazolines and pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,4,5-Trisubstituted imidazolines and pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4,5-Trisubstituted imidazolines and pharmaceutical composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1018498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.